X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALEMBIC LTD ALEMBIC PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 27.7 122.5 22.6% View Chart
P/BV x 6.3 4.6 138.9% View Chart
Dividend Yield % 0.7 0.2 302.3%  

Financials

 ALEMBIC PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
ALEMBIC LTD
Mar-16
ALEMBIC PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs79253 1,499.4%   
Low Rs44329 1,511.9%   
Sales per share (Unadj.) Rs167.04.7 3,538.8%  
Earnings per share (Unadj.) Rs38.28.8 435.0%  
Cash flow per share (Unadj.) Rs42.09.0 466.4%  
Dividends per share (Unadj.) Rs4.000.15 2,666.7%  
Dividend yield (eoy) %0.60.4 177.3%  
Book value per share (Unadj.) Rs84.927.7 306.2%  
Shares outstanding (eoy) m188.52267.03 70.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.78.7 42.5%   
Avg P/E ratio x16.24.7 345.8%  
P/CF ratio (eoy) x14.74.6 322.4%  
Price / Book Value ratio x7.31.5 491.1%  
Dividend payout %10.51.7 613.1%   
Avg Mkt Cap Rs m116,38310,962 1,061.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,214238 1,770.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,4871,260 2,498.4%  
Other income Rs m55264 20.9%   
Total revenues Rs m31,5421,524 2,069.6%   
Gross profit Rs m10,06083 12,149.5%  
Depreciation Rs m72261 1,176.1%   
Interest Rs m370 12,266.7%   
Profit before tax Rs m9,356285 3,284.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-22,096 -0.1%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m2,1606 35,413.1%   
Profit after tax Rs m7,1942,343 307.1%  
Gross profit margin %31.96.6 486.3%  
Effective tax rate %23.12.1 1,078.4%   
Net profit margin %22.8185.9 12.3%  
BALANCE SHEET DATA
Current assets Rs m15,0661,689 892.1%   
Current liabilities Rs m7,674486 1,578.4%   
Net working cap to sales %23.595.4 24.6%  
Current ratio x2.03.5 56.5%  
Inventory Days Days67217 30.9%  
Debtors Days Days4181 50.1%  
Net fixed assets Rs m8,2371,624 507.2%   
Share capital Rs m377534 70.6%   
"Free" reserves Rs m15,4165,960 258.7%   
Net worth Rs m16,0057,404 216.2%   
Long term debt Rs m0104 0.0%   
Total assets Rs m24,5948,010 307.0%  
Interest coverage x255.2950.7 26.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.2 813.7%   
Return on assets %29.429.3 100.5%  
Return on equity %44.931.6 142.1%  
Return on capital %58.731.3 187.5%  
Exports to sales %55.72.9 1,893.5%   
Imports to sales %10.428.9 36.1%   
Exports (fob) Rs m17,55137 47,306.7%   
Imports (cif) Rs m3,283364 902.7%   
Fx inflow Rs m17,81137 48,006.7%   
Fx outflow Rs m5,318365 1,457.2%   
Net fx Rs m12,493-328 -3,810.5%   
CASH FLOW
From Operations Rs m9,304346 2,692.1%  
From Investments Rs m-3,105-48 6,522.7%  
From Financial Activity Rs m-1,959-301 650.9%  
Net Cashflow Rs m4,240-3 -141,333.3%  

Share Holding

Indian Promoters % 74.1 64.0 115.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.2 1,450.0%  
FIIs % 9.1 9.7 93.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 26.1 53.3%  
Shareholders   49,328 54,701 90.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TTK HEALTHCARE  UNICHEM LAB  CIPLA  ELDER PHARMA  SUVEN LIFE  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; IT & Healthcare Stocks Gain(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.16% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.43%.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 17, 2018 11:33 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS